Over the past few years there have been several exciting drug developments for use in veterinary patients that are specifically marketed for the treatment of neoplastic disease. These have largely arisen due to an increased understanding of the science behind cancer development and treatment, such as the underlying role of mutations/dysregulation of the c-kit gene in mast cell tumours. There have also been some alterations in the way traditional medications are administered to exploit certain biological processes such as tumour blood vessel formation and growth (eg, metronomic chemotherapy). This article summarises some of these newer, emerging treatments.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.